Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
2010

Hydrocephalus Treatment in African Infants with Myelomeningocele

publication Evidence: moderate

Author Information

Author(s): Benjamin C Warf

Primary Institution: Harvard Medical School, Children's Hospital Boston

Hypothesis

Is endoscopic treatment for hydrocephalus more effective than traditional methods in African infants?

Conclusion

Endoscopic treatment for hydrocephalus is safe and effective, especially for infants with myelomeningocele.

Supporting Evidence

  • Endoscopic treatment was significantly more successful than ETV alone in infants under one year.
  • Infants with myelomeningocele had a 76% success rate with the new treatment.
  • Community-based rehabilitation programs were crucial for improving survival rates.

Takeaway

Doctors found that a special surgery helps babies with a brain condition do better than the usual treatment. Also, being part of a community program helps them live longer.

Methodology

The study explored endoscopic treatment methods and evaluated outcomes in infants with hydrocephalus.

Potential Biases

Potential bias due to the socio-economic factors affecting treatment access.

Limitations

Access to treatment is limited by poverty and infrastructure issues.

Participant Demographics

Infants in Uganda with hydrocephalus, particularly those with myelomeningocele.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-8454-7-S1-S3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication